2018
DOI: 10.1111/tri.13290
|View full text |Cite
|
Sign up to set email alerts
|

The 1-year Renal Biopsy Index: a scoring system to drive biopsy indication at 1-year post-kidney transplantation

Abstract: Surveillance biopsies after renal transplantation remain debatable. To drive the decision of such intervention, we propose a predictive score of abnormal histology at 1-year post-transplantation, named 1-year Renal Biopsy Index (1-RBI). We studied 466 kidney recipients from the DIVAT cohort alive with a functioning graft and a surveillance biopsy at 1-year post-transplantation. Patients displaying abnormal histology (49%) (borderline, acute rejection, interstitial fibrosis and tubular atrophy [IFTA] grade 2 or… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
7
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 8 publications
(7 citation statements)
references
References 26 publications
0
7
0
Order By: Relevance
“…LASSO regression is one of the most useful tools to select features for classification and survival prognosis determination ( Song et al, 2020 ). It can obtain fewer and more representative variable combinations from a large number of variables while avoiding model overfitting ( Giral et al, 2018 ; Patel et al, 2018 ). However, LASSO regression also has shortcomings.…”
Section: Discussionmentioning
confidence: 99%
“…LASSO regression is one of the most useful tools to select features for classification and survival prognosis determination ( Song et al, 2020 ). It can obtain fewer and more representative variable combinations from a large number of variables while avoiding model overfitting ( Giral et al, 2018 ; Patel et al, 2018 ). However, LASSO regression also has shortcomings.…”
Section: Discussionmentioning
confidence: 99%
“…When serum creatinine levels rise or eGFR falls, allograft damage may have progressed to the point that it is no longer reversible [4]. Accordingly, allograft biopsy was considered the golden choice to analyze allograft injury and differentiate among the different etiologies, despite its impediments, such as infection, bleeding, and even allograft loss [5]. However, the regular evaluation of CAI still can not be exactly.…”
Section: Introductionmentioning
confidence: 99%
“…Processes at the molecular level involved in chronic allograft injury occur very early, but they do not manifest clinically and cannot be detected by standard methods [7]. Currently, assessment of IFTA is only possible with renal biopsy, which is an invasive procedure [8]. Postoperative management of kidney transplant recipients includes protocolar biopsies which are performed without specific clinical indications to detect subclinical changes [9].…”
Section: Introductionmentioning
confidence: 99%